Effects of Nicotine on the Cardiovascular System
Cigarette smoking is the leading cause of death in the United States. The addictive component of tobacco is nicotine, which has been found to be responsible for many of the adverse cardiovascular effects normally associated with smoking. A number of studies have demonstrated that vascular tone can be increased or decreased in response to nicotine depending on the origin of the blood vessels examined, the concentration of nicotine used, and the method of administration. These effects can be a result of differential gene expression, abnormal growth and proliferation, endothelial damage, superoxide radical ion production, and altered cation permeability. Nicotine also affects hemostasis by increasing thrombogenesis and platelet aggregation. In addition, nicotine influences hematopoiesis by altering the hematocrit, the expression of adhesion molecules, the erythrocyte-leukocyte ratio, and the specific leukocyte composition in the blood. In this paper we review these implications of nicotine use and also examine the role of nicotine in the development of several cardiovascular diseases.
Keywords: atherosclerosis; cardiovascular system; endothelial nitric oxide synthase; endothelium; nicotine; nitric oxide
Document Type: Review Article
Affiliations: Department of Chemistry & Biochemistry, California State University, San Bernardino, CA 92407, USA.
Publication date: 01 April 2005
- Vascular Disease Prevention publishes reviews as well as original papers to update all those concerned with this topic at the clinical or scientific level. In addition to clinically relevant topics, we consider reviews and original papers dealing with the more scientific aspects of vascular disease prevention. This includes the evaluation of emerging vascular risk factors, research dealing with the pathogenesis of atherosclerosis and the investigation of new treatment options both at the clinical and scientific level (e.g. epidemiology, patient-based studies, experimental models, in vitro experiments or molecular research). Therefore, another function of Vascular Disease Prevention is to bridge the gap between clinical practice and ongoing laboratory-based research.
In particular, we welcome critical reviews and comments on recent trials. This is a topic that requires regular updates because of the large number of trials published every year.
Debates are encouraged in the correspondence section of this journal.
The editorial structure of Vascular Disease Prevention is set up with the aim of dealing with the submitted material as rapidly as possible. Specialist editors will provide a more expert and rapid assessment unlike a more centralized editorial structure.
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content